Graeme Melville is a senior nuclear researcher at St George Hospital in Sydney, Australia. In the past he was a professional tennis player, NASA astrophysics researcher (Magellan Project), university lecturer and government science policy advisor. Dr Melville has worked in a senior position with the Department of Defence and published many papers in astrophysics and nuclear physics as well as being Editor-in-Chief of an international journal. He was the recipient of the 2005 ‘Physics in Industry Day’ award and 2007 ‘Research Futures Forum’ prize. He is currently the Chairman of the Australian Institute of Physics (NSW) and has published two books. His current research at St George Hospital in Sydney involves producing Ac-225 for ‘Targeted Alpha Therapy’ (TAT) - a new kind of cancer treatment. Graeme Melville is a senior nuclear researcher at St George Hospital in Sydney, Australia. In the past he was a professional tennis player, NASA astrophysics researcher (Magellan Project), university lecturer and government science policy advisor. Dr Melville has worked in a senior position with the Department of Defence and published many papers in astrophysics and nuclear physics as well as being Editor-in-Chief of an international journal. He was the recipient of the 2005 ‘Physics in Industry Day’ award and 2007 ‘Research Futures Forum’ prize. He is currently the Chairman of the Australian Institute of Physics (NSW) and has published two books. His current research at St George Hospital in Sydney involves producing Ac-225 for ‘Targeted Alpha Therapy’ (TAT) - a new kind of cancer treatment.

Genetics and Molecular Biology